biolog
autophagi
health
diseas
condit
intens
analyz
decad
sever
potenti
intervent
induc
autophagi
preclin
research
howev
none
intervent
readi
translat
clinic
practic
yet
topic
current
review
molecular
regul
autophagi
glucagon
glucagonlik
peptid
glp
enzym
dipeptidyl
glucagon
wellknown
polypeptid
induc
autophagi
contrast
shown
inhibit
glucagon
secret
also
relat
induct
autophagi
inhibitor
induc
autophagi
manner
divers
effect
could
relev
analyz
distinct
molecular
regul
autophagi
glucagon
inhibitor
addit
potenti
contribut
autophagi
glucagon
bariatr
surgeri
discuss
recent
advanc
incretinbas
drug
open
new
avenu
manag
diabet
clinic
prescrib
two
type
incretinbas
drug
glucagonlik
peptid
receptor
agonist
dipeptidyl
inhibitor
produc
intestin
lcell
proteolyt
process
proglucagon
prog
immedi
degrad
halflif
approxim
min
develop
avoid
cleavag
introduc
mutat
amino
acid
residu
target
exenatid
polypeptid
isol
venom
gila
monster
lizard
homolog
human
use
clinic
altern
extend
halflif
endogen
inhibitor
prescrib
recent
clinic
trial
marso
et
al
marso
et
al
rosenstock
et
al
investig
safeti
efficaci
incretinbas
drug
provid
divers
interpret
provoc
intellectu
curios
regard
biolog
incretin
hormon
incretinbas
drug
specif
focus
pleiotrop
effect
autophagi
cellular
mechan
promot
cell
surviv
nutrient
deplet
may
also
relev
basal
nutrient
excess
condit
cellular
process
specifi
format
autophagosom
cytosol
compon
captur
fuse
lysosom
promot
degrad
andor
recycl
content
autophag
process
consist
four
stage
initi
nucleat
elong
fusiondegrad
codogno
et
al
nutrient
deplet
autophagi
provid
essenti
compon
energi
product
biosynthesi
howev
also
act
similar
manner
recycl
damag
organel
unnecessari
protein
foreign
substanc
qualiti
mainten
intracellular
compon
ueno
komatsu
circumst
nutrient
excess
autophagi
play
import
role
elimin
unfold
protein
toxic
aggreg
facilit
endoplasm
reticulum
er
homeostasi
detail
mechan
biolog
autophagi
summar
subsequ
section
issu
autophagi
defect
certain
diseas
subject
extens
research
addit
liver
autophagi
defect
shown
occur
sever
metabol
diseas
obes
steatosi
type
diabet
ueno
komatsu
earli
work
liver
research
indic
link
regul
gastrointestin
hormon
liver
autophagi
ueno
komatsu
interestingli
incretin
hormon
inhibitor
associ
amelior
steatosi
rowland
et
al
zheng
et
al
drug
shown
induc
autophagi
variou
cell
type
muras
et
al
rowland
et
al
zheng
et
al
review
investig
potenti
involv
autophagi
induct
incretinbas
dug
addit
focus
glucagon
known
polypeptid
regul
glucos
level
classic
molecul
induc
autophagi
produc
proteolyt
cleavag
precursor
polypeptid
pprog
muller
et
al
pprog
gene
gcg
express
specif
popul
enteroendocrin
cell
lcell
intestin
mucosa
islet
cell
pancrea
neuron
within
nucleu
solitari
tract
nt
han
et
al
jin
et
al
regul
gcg
transcript
process
complet
known
distinct
pattern
mrna
express
report
intestin
endocrin
cell
pancreat
islet
jin
yi
et
al
chiang
et
al
muller
et
al
addit
uniqu
transcript
control
cell
type
posttransl
process
prohormon
play
import
role
major
cell
type
produc
prog
peptid
addit
glucagon
glucagonlik
oxyntomodulin
glicentin
glicentinrel
pancreat
polypeptid
grpp
major
proglucagon
fragment
mpgf
synthes
prog
howev
specif
biolog
function
fragment
identifi
figur
posttransl
regul
prog
peptid
respect
cell
type
reli
tissuespecif
posttransl
modif
prohormon
convertas
pc
intestin
lcell
neuron
nt
predomin
express
oxyntomodulin
seen
physiolog
relev
tucker
et
al
larsen
et
al
vrang
et
al
pancreat
high
level
respons
predomin
glucagon
synthesi
figur
holst
et
al
also
express
brain
coloc
gcg
addit
express
lower
level
ratio
glucagon
express
islet
cell
shown
increas
progress
diabet
omalley
et
al
gcg
express
prog
level
rel
lower
proxim
gut
higher
distal
part
highest
express
colon
bryant
bloom
associ
autophagi
glucagon
report
approxim
year
ago
christian
de
duve
report
acid
phosphataseposit
saclik
particl
rat
liver
cytoplasm
de
duve
et
al
electron
microscopi
analysi
reveal
particl
surround
lipoprotein
membran
novikoff
et
al
later
show
acid
hydrolas
organel
subsequ
name
lysosom
secret
glucagon
recogn
glucagon
receptor
g
proteincoupl
receptor
hepatocyt
subsequ
adenyl
cyclasemedi
product
second
messeng
camp
stimul
rise
intracellular
level
camp
activ
protein
kinas
pka
inhibit
saltinduc
kinas
sik
pka
phosphoryl
cyclic
amprespons
elementbind
protein
creb
sik
dephosphoryl
crebregul
transcript
coactiv
crtc
creb
togeth
crtc
upregul
creb
target
gene
gluconeogenesisrel
gene
nuclear
receptor
subfamili
group
member
tfeb
regul
gene
express
autophagi
protein
ueno
komatsu
semin
work
ashford
porter
found
glucagon
administr
increas
autophagi
liver
subsequ
role
glucagon
hepatocyt
autophagi
induct
confirm
vivo
studi
rat
arstila
trump
guder
et
al
deter
effect
glucagon
autophagi
like
tissu
specif
manner
mortimor
poso
glucagon
could
induc
autophagi
increas
size
number
autophag
vacuol
guder
et
al
deter
shelburn
et
al
addit
glucagon
enhanc
fragil
hepat
lysosom
mechan
osmot
alter
sediment
properti
deter
de
duve
effect
glucagon
hepat
lysosom
appear
min
intraperiton
administr
glucagon
peak
min
disappear
approxim
h
deter
de
duve
number
hepat
lysosom
increas
condit
associ
increas
endogen
glucagon
level
starvat
guder
et
al
hypoglycemia
induc
phlorizin
becker
cornwalljr
type
diabet
amherdt
et
al
support
find
signific
correl
paramet
hepat
lysosom
volum
densiti
plasma
glucagon
observ
rat
type
diabet
induc
streptozotocin
insulin
intervent
rat
led
suppress
glucos
glucagon
level
amherdt
et
al
addit
pancreat
transplant
normal
liver
autophagi
level
rat
streptozotocininduc
diabet
restor
insulin
glucagon
level
brekk
et
al
glucagon
relev
glucagonmedi
glycogenolysi
glycogen
granul
select
envelop
autophagosom
catabol
glucos
special
type
autophagi
term
glycophagi
shown
suppress
glucagon
level
menti
et
al
even
though
tissu
divers
effect
glucagon
autophagi
induct
liver
establish
target
organ
glucagoninduc
autophagi
therefor
point
view
signal
could
relev
inhibit
autophagi
induct
liver
recent
howev
also
implic
induct
autophagi
liver
et
al
cell
zummo
et
al
arden
well
protect
cell
insult
induc
chronic
exposur
excess
nutrient
via
induct
autophagosomallysosom
fusion
zummo
et
al
arden
agonist
polypeptid
human
deriv
venom
gila
monster
lizard
also
shown
enhanc
lysosom
function
improv
autophagosom
clearanc
protect
islet
injuri
rat
model
tacrolimusinduc
diabet
lim
et
al
inde
studi
cell
rat
administ
show
reduct
number
autophagosom
lim
et
al
therefor
certain
environ
contrari
hypothesi
antiglucagon
antiautophag
signal
effect
receptor
signal
could
relev
acceler
effect
autophagosomallysosom
fusion
posit
mediat
autophag
flux
howev
role
autophagi
complex
like
depend
stress
condit
rat
model
fed
high
level
fructos
analog
intervent
induc
notabl
inhibit
cell
autophagi
enhanc
cell
mass
function
maiztegui
et
al
detail
molecular
regul
autophagi
system
cell
via
receptor
signal
requir
investig
liver
potenti
target
organ
autophagi
et
al
among
organ
level
liver
highest
transport
hepat
portal
vein
gut
intervent
analog
could
amelior
sever
aspect
liver
injuri
dalessio
et
al
cantini
et
al
influenc
hepat
gluconeogenesi
glycogen
synthesi
glycolysi
figur
effect
receptor
essenti
presenc
controversi
hepatocyt
focu
intens
discuss
protein
express
report
transform
human
hepatocyt
cell
line
primari
human
hepatocyt
gupta
et
al
even
though
confirm
express
hepatocyt
research
suggest
effect
inde
event
bullock
et
al
flock
et
al
aviv
et
al
toma
et
al
altern
possibl
explan
could
base
degrad
product
studi
indic
cellpenetr
peptid
requir
elahi
et
al
amid
novel
pentapeptid
cleavag
product
modul
wholebodi
glucos
metabol
dog
elahi
et
al
nonapeptid
amid
preserv
pancreat
cell
glucolipotox
liu
et
al
activ
pka
wnt
signal
review
jin
weng
benefici
effect
fragment
report
includ
kidney
protect
effect
dbdb
mice
diabet
moellmann
et
al
whether
deriv
fragment
relev
liver
autophagi
induct
known
requir
investig
seri
experi
provid
evid
agonist
amelior
hepat
steatosi
metabol
defect
antisteatot
metabol
effect
liver
could
involv
ampk
activ
suppress
mtor
pathway
liraglutid
shown
halt
progress
steatosi
associ
induct
autophagi
via
activ
ampk
suppress
mtor
pathway
et
al
activ
macroand
chaperonemedi
autophagi
could
protect
hepatocyt
fatti
acidrel
apoptosi
suppress
dysfunct
er
stress
respons
therapi
shown
reliev
burden
er
reduc
er
stress
decreas
subsequ
hepatocyt
apoptosi
sharma
et
al
altern
explan
autophagi
induct
could
associ
suppress
oxid
stress
agonist
shown
reduc
oxid
stress
divers
preclin
studi
endogen
antioxid
system
remov
free
radic
appropri
oxid
stress
accumul
free
radic
acceler
varieti
diseas
condit
diabet
complic
cancer
neuron
disord
cellular
defens
system
combat
reactiv
oxygen
speci
ro
reli
presenc
antioxid
scaveng
ro
induc
gene
involv
cytoprotect
neutral
ro
kaspar
et
al
nuclear
factor
erythroid
factor
transcript
factor
master
regul
redox
balanc
respons
transcript
variou
antioxid
detoxif
gene
bind
antioxid
respons
element
are
kaspar
et
al
agonist
shown
induc
cell
oh
jun
cell
expos
oxid
stress
known
ubiquitinbind
protein
autophagosom
cargo
protein
phosphoryl
phosphoryl
form
physic
interact
adaptor
ubiquitin
ligas
complex
high
affin
ueno
komatsu
interact
result
suppress
ubiquitin
phosphoryl
complex
select
degrad
autophagi
ueno
komatsu
thereaft
stabil
transloc
nucleu
induc
express
variou
essenti
cytoprotect
gene
nad
p
h
dehydrogenas
quinon
glutathion
stransferas
glutamatecystein
ligas
catalyt
subunit
heme
oxygenas
jain
et
al
komatsu
et
al
lau
et
al
taguchi
et
al
ichimura
et
al
sestrin
also
known
intracellular
leucin
sensor
neg
regul
signal
bind
complex
function
scaffold
protein
autophagi
bae
et
al
sestrin
also
induc
condit
stress
yang
et
al
activ
might
regul
select
autophagi
metabol
stress
therefor
activ
could
relev
autophagi
studi
need
associ
sestrin
yet
confirm
member
serin
peptidaseprolyl
oligopeptidas
gene
famili
first
found
cell
differenti
antigen
also
cell
surfac
aminopeptidas
display
numer
biolog
function
proteas
activ
interact
adenosin
deaminas
extracellular
matrix
protein
coreceptor
activ
mediat
viral
entri
regul
intracellular
signal
kameoka
et
al
kahn
et
al
lambeir
et
al
lopezotin
matrisian
lu
et
al
preclin
studi
shown
potenti
link
inhibit
autophagi
induct
leptindefici
obob
mice
sitagliptin
mgkg
daili
week
amelior
weight
gain
metabol
disord
steatosi
liver
well
insulin
sensit
studi
sitagliptin
increas
ampk
phosphoryl
decreas
mtor
phosphoryl
associ
restor
beclin
messeng
rna
express
suppress
obob
mice
addit
rel
level
significantli
diminish
obob
mice
restor
basal
level
sitagliptin
zheng
et
al
anoth
report
show
autophag
respons
significantli
diminish
oletf
rat
experiment
myocardi
infarct
associ
defici
activ
signal
increas
interact
key
molecular
event
suppress
autophagi
intervent
inhibitor
vildagliptin
inhibit
interact
enhanc
protein
autophagosom
noninfarct
region
oletf
rat
without
normal
either
signal
effect
vildagliptin
heart
autophagi
associ
surviv
rate
oletf
rat
chloroquin
autophagi
inhibitor
diminish
benefici
effect
vildagliptin
muras
et
al
report
indic
inhibitor
could
associ
induct
autophagi
howev
underli
mechan
inhibit
relat
autophagi
induct
absolut
clear
may
involv
increas
level
inhibitor
treatment
inhibitor
enhanc
insulin
secret
induct
autophagi
signal
islet
highfatf
mice
effect
inhibit
autophagi
signal
complet
abolish
antagonist
exendin
coadministr
liu
et
al
induct
pleiotrop
effect
inhibitor
may
relev
mechan
autophagi
induct
inhibit
interact
extracellular
matrix
import
determin
cell
fate
integrin
glycoprotein
play
vital
role
cellcel
cellmatrix
interact
heterodim
eighteen
eight
subunit
integrin
known
display
divers
ligand
bind
signal
properti
pozzi
zent
integrin
subunit
consist
extracellular
domain
import
ligand
bind
properti
contain
transmembran
domain
short
cytoplasm
tail
could
interact
divers
cytosol
transmembran
protein
consist
focal
adhes
complex
except
pozzi
zent
integrin
display
physic
interact
sever
extracellular
matrix
ecm
glycoprotein
collagen
fibronectin
laminin
cellular
receptor
plow
et
al
hyne
integrin
essenti
molecul
actin
cytoskeleton
remodel
regul
cell
signal
regul
biolog
cellular
function
park
et
al
integrin
display
intracellular
signal
ligand
bind
outsidein
signal
ratnikov
et
al
altern
integrin
alter
highto
lowaffin
conform
facilit
specif
ligand
bind
insideout
signal
luo
et
al
activ
statu
integrin
reli
cell
type
cell
adher
basement
membran
integrin
activ
contrast
integrin
inact
circul
platelet
leukocyt
induc
platelet
aggreg
stimul
inflammatori
respons
integrin
contain
neither
catalyt
site
kinas
activ
play
role
bridg
ecm
actin
cytoskeleton
interact
ecm
actin
cytoskeleton
integrin
allow
integrin
maintain
cytoskelet
organ
cell
motil
intracellularsign
pathway
cell
surviv
cell
shape
cell
prolifer
angiogenesi
arnaout
et
al
luo
et
al
inde
molecul
interact
key
integrin
integrin
figur
form
heterodim
least
integrin
biolog
function
figur
may
target
integrin
suppress
autophagi
cell
membran
display
interact
integrin
integrin
import
focal
adhes
complex
integrin
cell
adhes
complex
potenti
inhibit
anoiki
autophagi
inde
autophagi
import
biolog
mechan
protect
cell
anoiki
well
autophagi
also
target
inhibit
focal
adhes
complex
hub
integrin
act
receptor
specif
ecm
compon
reveal
kidney
epitheli
cell
glynn
et
al
cell
lymphoma
elia
et
al
loss
membranebound
associ
suppress
phosphoryl
integrin
play
key
role
cellular
adhes
integrin
ecm
sato
et
al
shown
inhibitor
linagliptin
suppress
interact
integrin
subsequ
inhibit
endotheli
mesenchym
transit
program
shi
et
al
kanasaki
fibrogen
program
associ
inhibit
autophagi
singh
et
al
interestingli
addit
biolog
import
integrin
suppress
autophagi
autophagi
pathway
target
integrin
nutrient
starvat
vlahaki
debnath
autophagi
degrad
focal
adhes
protein
promot
turnov
molecul
vlahaki
debnath
addit
integrinmedi
cell
adhes
ecm
shown
protect
cell
anoiki
apoptosi
induc
lack
correct
cellecm
attach
integrinmedi
interact
ecm
lost
cell
induc
autophagi
surviv
figur
autophagi
induct
shown
promot
surviv
epitheli
cell
adjust
absenc
cellmatrix
contact
result
anoiki
resist
yang
et
al
chen
et
al
talukdar
et
al
figur
autophagi
inhibit
either
rna
interfer
harbor
oncogen
cell
lost
abil
combat
anoiki
figur
bariatr
surgeri
includ
rouxeni
rygb
gastric
band
sleev
gastrectomi
sg
biliopancreat
divers
bpd
benefici
intervent
treatment
obes
reduct
bodi
weight
associ
amelior
liver
steatosi
metabol
defect
howev
detail
molecular
mechan
benefici
metabol
effect
bariatr
surgeri
complet
establish
report
indic
amelior
metabol
profil
gastrectomi
associ
autophagi
induct
soussi
et
al
sever
possibl
explan
made
interest
phenomenon
bariatr
surgeri
signific
alter
anatom
structur
induc
chang
integr
respons
eat
includ
cephal
phase
chew
tast
gastric
phase
intestin
phase
gut
peptid
absorpt
phase
glucos
metabol
liver
bile
acid
phase
larg
intestin
microbiota
phase
summar
ref
quercia
et
al
molecul
describ
review
could
also
notabl
signific
autophagi
induct
bariatr
surgeri
figur
stomach
gastric
empti
regul
gastric
content
neural
hormon
influenc
alter
bariatr
surgeri
describ
earlier
acceler
gastric
empti
time
liquid
slower
gastric
empti
time
solid
report
rygb
horowitz
et
al
kotler
et
al
report
faster
intestin
transit
time
increas
enteroglucagon
level
patient
greater
weight
loss
compar
weightstabl
patient
term
enteroglucagon
report
necessarili
includ
glucagon
cross
reaction
sever
glucagon
sequencecontain
polypeptid
time
report
presenc
extrapancreat
glucagon
secret
human
focu
intens
discuss
year
even
though
evid
conflict
investig
report
glucagon
respons
total
pancreatectomi
present
anim
sutherland
de
duve
matsuyama
foa
vranic
et
al
muller
et
al
doi
et
al
gotoh
et
al
human
unger
et
al
barn
bloom
villanueva
et
al
boden
et
al
karesen
et
al
sudo
et
al
dammann
et
al
holst
et
al
yasui
polonski
et
al
bajoruna
et
al
b
ohtsuka
et
al
tanjoh
et
al
challeng
point
recent
analyt
method
glucagon
suffici
sensit
specif
justifi
decis
statement
absenc
presenc
extrapancreat
fulli
process
acid
glucagon
tanjoh
et
al
recent
sandwich
enzymelink
immunosorb
assay
elisa
util
combin
cand
ntermin
antiglucagon
antibodi
emerg
elisa
system
theoret
could
elimin
crossreact
truncat
elong
form
glucagon
contain
polypeptid
wewer
albrechtsen
et
al
lund
et
al
studi
patient
underw
total
pancreatectomi
analyz
plasma
glucagon
level
expect
gastrointestin
anatomi
remark
chang
includ
remov
pylor
sphincter
duodenum
total
pancreatectomi
therefor
follow
ingest
meal
nutrient
rerout
deliv
directli
stomach
jejunum
manner
similar
bariatr
surgeri
previous
describ
uniqu
point
studi
lund
et
al
util
novel
sandwich
enzymelink
immunosorb
assay
plasma
glucagon
also
mass
spectrometrybas
proteom
confirm
acid
circulatori
glucagon
level
patient
without
pancrea
basal
glucagon
level
patient
exhibit
lower
trend
glucos
challeng
gastrointestin
tract
exert
signific
hyperglucagonemia
patient
lund
et
al
also
confirm
intraven
glucos
infus
attenu
plasma
glucagon
level
direct
focu
gastrointestin
tract
unfortun
direct
evid
indic
hyperglucagonemia
bariatr
surgeri
yet
higher
glucagon
releas
within
first
h
higher
trend
peak
level
glucagon
post
rygb
patient
compar
sg
neither
oper
group
recent
report
svane
et
al
find
suggest
alter
glucagon
secret
possibl
hyperglucagonemia
could
induc
bariatr
surgeri
relev
system
physiolog
alter
includ
autophagi
figur
subsequ
induct
autophagi
could
influenc
health
individu
obes
also
lean
malnourish
patient
gastrectomi
research
would
requir
field
potenti
contribut
pathobiolog
alter
occur
bariatr
surgeri
seen
advers
outcom
bariatr
surgeri
late
dump
syndrom
wellknown
hypoglycem
event
occur
h
meal
gastric
surgeri
complic
surgeri
obes
well
underli
caus
late
dump
syndrom
complet
understood
gener
hypothes
postop
elev
incretin
hormon
especi
level
lead
pancreat
hypertrophi
figur
hypertrophi
stimul
insulin
secret
hypoglycem
symptom
theori
support
observ
hyperinsulinem
hypoglycemia
frequent
occur
figur
possibl
alter
gut
environ
relationship
autophagi
bariatr
surgeri
sleev
gastrectomi
sg
rouxeni
gastric
bypass
gb
common
surgic
procedur
bariatr
surgeri
bariatr
surgeri
rapid
entri
nutrient
like
induc
secret
addit
glucagon
potenti
increas
variousunknown
mechan
gutderiv
peptid
pyy
could
inhibit
glucagon
express
gip
might
stimul
glucagon
express
howev
observ
investig
pancreat
cell
regul
gut
glucagon
found
gip
gastric
inhibitori
peptid
pyy
peptid
yy
glucagonlik
patient
underw
resect
part
stomach
gastrojejunostomi
bypass
pyloru
therefor
induc
level
oral
glucos
meal
test
consist
report
rygb
yi
et
al
bpd
jin
weng
sg
moellmann
et
al
figur
even
though
none
theori
mechanist
proven
hypoglycem
event
increas
could
associ
hepat
autophagi
et
al
report
studi
rat
obes
diabet
rygb
led
signific
induct
autophagi
liver
restor
autophagi
level
liver
associ
reduc
level
hepat
lipid
increas
autophagi
liver
rygb
well
correl
plasma
level
therefor
induct
bariatr
surgeri
would
also
lead
signific
stimul
autophagi
figur
review
focus
associ
drug
physiolog
autophagi
propos
chang
gastrointestin
tract
induc
food
bypass
intestin
would
relev
induct
autophagi
via
secret
andor
glucagon
kk
concept
design
major
contribut
write
manuscript
ek
made
figur
discuss
dk
intellectu
input
project
studi
essenti
support
grant
japan
diabet
foundat
work
partial
support
grant
japan
societi
promot
scienc
kk
dk
work
partial
support
grant
promot
research
award
kk
kanazawa
medic
univers
boehring
ingelheim
mitsubishi
tanab
pharma
ono
pharmaceut
contribut
establish
divis
anticipatori
molecular
food
scienc
technolog
